Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-26-124373·Coastlands Capital LP
Schedule 13G ownership disclosure
Sutro Biopharma, Inc.
Common Stock, par value $0.001 per share · CUSIP: 869367201
Event date: 2026-11-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Coastlands Capital LP
Shares: 852,669.00 · Class: 5.14%
- Coastlands Capital Partners LP
Shares: 852,669.00 · Class: 5.14%
- Coastlands Capital GP LLC
Shares: 852,669.00 · Class: 5.14%
- Coastlands Capital LLC
Shares: 852,669.00 · Class: 5.14%
- Matthew D. Perry
Shares: 852,669.00 · Class: 5.14%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-124373
- Form type
- SCHEDULE 13G
- Filer
- Coastlands Capital LP
- CIK
- CIK 2068530
- Filed
- Nov 09, 2026
- Reporting period
- Nov 05, 2026
- Description
- Schedule 13G beneficial ownership